HLN as reported
Haleon plc reported £11.0B of revenue over the trailing twelve months, +16% on the year before. 10 reported series are charted on this page, each one as filed.
£11.0B
Revenue, trailing twelve months · to FY2025 · +16% against the twelve months before
- Net Income
- £1.67B
Net Income · +20% year on year · trailing twelve months to FY2025
- Free Cash Flow
- £2.31B
Free Cash Flow · +105% year on year · trailing twelve months to FY2025
- Op Margin
- 22%
Op Margin · trailing twelve months to FY2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | £11.0B | +16% | FY2025 |
| Net Income | £1.67B | +20% | FY2025 |
| EPS | £0.19 | +23% | FY2025 |
| Gross Margin | 64% | n/a | FY2025 |
| Op Margin | 22% | n/a | FY2025 |
| Net Margin | 15% | n/a | FY2025 |
| ROE | 10% | n/a | FY2025 |
| ROA | 5.1% | n/a | FY2025 |
| ROIC | 8.2% | n/a | FY2025 |
| Free Cash Flow | £2.31B | +105% | FY2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Haleon plc (HLN) - Revenue & ProfitRevenue & ProfitHaleon plc (HLN)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Drug Manufacturers - Specialty & Generic
The closest names by size in the same industry